Pharmaceutical & Biotech companies benefit from rigorous, data-driven safety science for drug and device development. By generating transparent, science-based safety profiles, ToxStrategies helps reduce development risks, prepare regulatory submissions, and build confidence with both regulators and investors.

For more information contact our team of experts lead by:
  • Marcie Wood
  • Nate Collins
  • Karen Dingley
  • Amy Kimzey
  • Kirsten Mease
  • Tom Monticello
  • Tim Robison
  • Kristina Ulrich

Divisions of ToxStrategies